TTY Biopharm Co (ROCO:4105) Change In Other Working Capital : NT$-142 Mil (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is TTY Biopharm Co Change In Other Working Capital?

TTY Biopharm Co's Change In Other Working Capital for the quarter that ended in Mar. 2024 was NT$-174 Mil. It means TTY Biopharm Co's Other Working Capital declined by NT$174 Mil from Dec. 2023 to Mar. 2024 .

TTY Biopharm Co's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was NT$-183 Mil. It means TTY Biopharm Co's Other Working Capital declined by NT$183 Mil from Dec. 2022 to Dec. 2023 .

TTY Biopharm Co Change In Other Working Capital Historical Data

The historical data trend for TTY Biopharm Co's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TTY Biopharm Co Change In Other Working Capital Chart

TTY Biopharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Other Working Capital

Get a 7-Day Free Trial

63.97

-196.95

224.52

134.41

-183.10

TTY Biopharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Other Working Capital	Get a 7-Day Free Trial															-215.22	-78.29	100.99	9.42	-174.03

TTY Biopharm Co Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-142 Mil.

TTY Biopharm Co Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of TTY Biopharm Co's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

TTY Biopharm Co (ROCO:4105) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TTY Biopharm Co Ltd (ROCO:4105) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3-1, Park Street, 3rd Floor, Nangang District, Taipei, TWN, 11503

Website

https://www.tty.com.tw

TTY Biopharm Co Ltd is engaged in the manufacturing and marketing of pharmaceuticals and chemical drugs. The company's operating segment includes Oncology, Health Care, Anti-Infection, Domestic Cardiovascular and Gastrointestinal Drugs, and other segments. It generates maximum revenue from the Oncology segment. Geographically, it derives a majority of revenue from Taiwan and also has a presence in European and Other Countries. Some of its products include Algitab, Alginos, Sulfin, Metacin, Cepiro, Brosym, Colimycin, Cubicin, and others.

TTY Biopharm Co (ROCO:4105) Headlines

No Headlines